I’ve learned to live in the present by avoiding clocks, a necessary change in my life after having breast cancer.

Partial nephrectomy showed similar overall and cancer-specific survival rates to radiofrequency ablation in patients with ...

The FDA has approved the first systemic therapy for patients with NSCLC or pancreatic adenocarcinoma with an NRG1 gene fusion.

Patients with locally advanced pancreatic cancer demonstrated a two-month difference in survival with tumor-treating fields ...